Get started
Author

Krisha Panchal

GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes
2025 · David J. Ramsey, Bhargav Makwana, et al. · JAMA Network Open · 62
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients With Type 2 Diabetes and Diabetic Retinopathy
2026 · Jui Shah, Bhargav Makwana, et al. · American Journal of Ophthalmology · 4
Comparison of American College of Cardiology/American Heart Association Cardiovascular Risk Score, Framingham Risk Scores, European Society of Cardiology Cardiovascular Disease Risk Calculator, QRISK3-2018 Risk Calculator in Patients Presenting with First Time with Myocardial Infarction: A Step toward the Development of Indian Cardiac Risk Score
2024 · Nishita Devang Solanki, Tejas Rajendarkumar Pandya, et al. · Apollo Medicine · 4
GLP-1 Receptor Agonist Treatment and Health Outcomes in Methadone-Treated Patients with Opioid Use Disorder and Diabetes
2026 · Jane Y. Pan, Igor Elman, et al. · Journal of General Internal Medicine · 2
Four-year antibiogram analysis of priority pathogens: guiding empirical therapy and monitoring resistance trends
2026 · Krisha Panchal, Nasiruddin Shaikh, et al. · Microbiology Spectrum · 1
Comparative health outcomes of buprenorphine versus methadone treatment for opioid use disorder: a retrospective propensity score-matched cohort study in the global federated electronic health record network
2026 · Igor Elman, Mark Albanese, et al. · BMJ Open
Antitubercular treatment-induced chronic progressive sensory-motor polyneuropathy with optic neuropathy
2024 · Mitul Jagdishbhai Makwana, Devang A. Rana, et al. · National Journal of Pharmacology and Therapeutics
Works count: 7
Citation count: 73
H-index: 3
I10-index: 1
Year
Topic
Type